FDA Fast Tracks Arvinas' and Pfizer’s Vepdegestrant for ER-Positive/HER2-Negative Breast Cancer

Vepdegestrant (ARV-471) is a noval PROTAC ER degrader found to harness the body’s own natural protein disposal system to eliminate disease-causing proteins.

Source link
#FDA #Fast #Tracks #Arvinas039 #Pfizers #Vepdegestrant #ERPositiveHER2Negative #Breast #Cancer